LEXICON PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lexicon Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2011 to Q3 2024.
  • Lexicon Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -108 %, a 9.06% increase year-over-year.
  • Lexicon Pharmaceuticals, Inc. annual Return On Equity for 2023 was -140 %, a 45.5% decline from 2022.
  • Lexicon Pharmaceuticals, Inc. annual Return On Equity for 2022 was -96 %, a 47.7% decline from 2021.
  • Lexicon Pharmaceuticals, Inc. annual Return On Equity for 2021 was -65 %, a 20.1% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -108 +10.8 +9.06% Jul 1, 2024 Sep 30, 2024
Q2 2024 -106 -8.53 -8.74% Apr 1, 2024 Jun 30, 2024
Q1 2024 -109 -4.25 -4.04% Jan 1, 2024 Mar 31, 2024
Q4 2023 -140 -43.7 -45.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -119 -26.7 -29% Jul 1, 2023 Sep 30, 2023
Q2 2023 -97.6 -4.05 -4.33% Apr 1, 2023 Jun 30, 2023
Q1 2023 -105 -29.9 -39.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -96 -31 -47.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -92.2 -45.8 -98.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -93.6 -122 -428% Apr 1, 2022 Jun 30, 2022
Q1 2022 -75.2 -61.8 -462% Jan 1, 2022 Mar 31, 2022
Q4 2021 -65 +16.3 +20.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -46.4 +121 +72.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 28.5 -19.7 -40.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -13.4 -139 -111% Jan 1, 2021 Mar 31, 2021
Q4 2020 -81.3 -385 -127% Oct 1, 2020 Dec 31, 2020
Q3 2020 -168 -2.54K -107% Jul 1, 2020 Sep 30, 2020
Q2 2020 48.2 -190 -79.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 126 -423 -77.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 304 +3.52K Oct 1, 2019 Dec 31, 2019
Q3 2019 2.37K +2.85K Jul 1, 2019 Sep 30, 2019
Q2 2019 238 +502 Apr 1, 2019 Jun 30, 2019
Q1 2019 549 +728 Jan 1, 2019 Mar 31, 2019
Q4 2018 -3.21K -3.09K -2432% Oct 1, 2018 Dec 31, 2018
Q3 2018 -476 -367 -340% Jul 1, 2018 Sep 30, 2018
Q2 2018 -265 -172 -186% Apr 1, 2018 Jun 30, 2018
Q1 2018 -180 -100 -126% Jan 1, 2018 Mar 31, 2018
Q4 2017 -127 -57.3 -82.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -108 -98.6 -1043% Jul 1, 2017 Sep 30, 2017
Q2 2017 -92.6 -83.5 -925% Apr 1, 2017 Jun 30, 2017
Q1 2017 -79.8 -75 -1580% Jan 1, 2017 Mar 31, 2017
Q4 2016 -69.6 -67.7 -3516% Oct 1, 2016 Dec 31, 2016
Q3 2016 -9.46 +29.4 +75.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -9.03 +37.8 +80.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -4.75 +48.3 +91% Jan 1, 2016 Mar 31, 2016
Q4 2015 -1.93 +62.9 +97% Oct 1, 2015 Dec 31, 2015
Q3 2015 -38.9 +52 +57.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -46.8 +22.3 +32.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -53 +8.25 +13.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -64.8 -13.6 -26.5% Oct 1, 2014 Dec 31, 2014
Q3 2014 -90.8 -41.8 -85.1% Jul 1, 2014 Sep 30, 2014
Q2 2014 -69.1 -24.3 -54.1% Apr 1, 2014 Jun 30, 2014
Q1 2014 -61.3 -19 -45% Jan 1, 2014 Mar 31, 2014
Q4 2013 -51.2 -8.56 -20.1% Oct 1, 2013 Dec 31, 2013
Q3 2013 -49.1 -4.27 -9.53% Jul 1, 2013 Sep 30, 2013
Q2 2013 -44.8 +2.37 +5.02% Apr 1, 2013 Jun 30, 2013
Q1 2013 -42.3 +7.83 +15.6% Jan 1, 2013 Mar 31, 2013
Q4 2012 -42.7 +10.1 +19.2% Oct 1, 2012 Dec 31, 2012
Q3 2012 -44.8 Jul 1, 2012 Sep 30, 2012
Q2 2012 -47.2 Apr 1, 2012 Jun 30, 2012
Q1 2012 -50.1 Jan 1, 2012 Mar 31, 2012
Q4 2011 -52.8 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.